Wellington Management Group
TEVA icon

Wellington Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$294K Sell
17,534
-120,602
-87% -$2.02M ﹤0.01% 1859
2025
Q1
$2.12M Sell
138,136
-47,776
-26% -$734K ﹤0.01% 1539
2024
Q4
$4.1M Buy
185,912
+3,816
+2% +$84.1K ﹤0.01% 1391
2024
Q3
$3.28M Sell
182,096
-4,111
-2% -$74.1K ﹤0.01% 1423
2024
Q2
$3.03M Sell
186,207
-52,593
-22% -$855K ﹤0.01% 1422
2024
Q1
$3.37M Sell
238,800
-15,860
-6% -$224K ﹤0.01% 1423
2023
Q4
$2.66M Sell
254,660
-89,927
-26% -$939K ﹤0.01% 1431
2023
Q3
$3.51M Buy
344,587
+102,261
+42% +$1.04M ﹤0.01% 1368
2023
Q2
$1.82M Buy
242,326
+46,712
+24% +$352K ﹤0.01% 1496
2023
Q1
$1.73M Buy
195,614
+176,286
+912% +$1.56M ﹤0.01% 1537
2022
Q4
$176K Hold
19,328
﹤0.01% 1948
2022
Q3
$156K Sell
19,328
-1,013
-5% -$8.18K ﹤0.01% 1986
2022
Q2
$153K Sell
20,341
-10,997
-35% -$82.7K ﹤0.01% 2023
2022
Q1
$294K Hold
31,338
﹤0.01% 2019
2021
Q4
$251K Hold
31,338
﹤0.01% 2108
2021
Q3
$305K Buy
31,338
+9,218
+42% +$89.7K ﹤0.01% 2041
2021
Q2
$219K Sell
22,120
-43,970
-67% -$435K ﹤0.01% 2079
2021
Q1
$763K Buy
66,090
+6,648
+11% +$76.8K ﹤0.01% 1771
2020
Q4
$574K Sell
59,442
-9,338
-14% -$90.2K ﹤0.01% 1688
2020
Q3
$620K Buy
68,780
+48,299
+236% +$435K ﹤0.01% 1664
2020
Q2
$252K Buy
20,481
+5,791
+39% +$71.3K ﹤0.01% 1777
2020
Q1
$132K Sell
14,690
-77,682,058
-100% -$698M ﹤0.01% 1867
2019
Q4
$761M Buy
77,696,748
+1,703,249
+2% +$16.7M 0.16% 146
2019
Q3
$523M Buy
75,993,499
+13,059,673
+21% +$89.9M 0.12% 188
2019
Q2
$581M Buy
62,933,826
+4,437,282
+8% +$41M 0.13% 176
2019
Q1
$917M Buy
58,496,544
+13,419,158
+30% +$210M 0.21% 118
2018
Q4
$695M Buy
45,077,386
+6,528,245
+17% +$101M 0.17% 139
2018
Q3
$830M Buy
38,549,141
+8,485,434
+28% +$183M 0.17% 138
2018
Q2
$731M Sell
30,063,707
-8,475,470
-22% -$206M 0.16% 150
2018
Q1
$659M Sell
38,539,177
-9,132,162
-19% -$156M 0.15% 158
2017
Q4
$903M Buy
47,671,339
+12,381,850
+35% +$235M 0.2% 122
2017
Q3
$621M Buy
35,289,489
+10,928,705
+45% +$192M 0.14% 169
2017
Q2
$809M Buy
24,360,784
+6,680,939
+38% +$222M 0.19% 128
2017
Q1
$567M Buy
17,679,845
+5,806,427
+49% +$186M 0.14% 173
2016
Q4
$430M Buy
11,873,418
+2,178,646
+22% +$79M 0.11% 191
2016
Q3
$446M Buy
9,694,772
+693,495
+8% +$31.9M 0.11% 191
2016
Q2
$452M Buy
9,001,277
+194,662
+2% +$9.78M 0.12% 184
2016
Q1
$471M Buy
8,806,615
+2,624,236
+42% +$140M 0.12% 176
2015
Q4
$406M Buy
6,182,379
+6,022,445
+3,766% +$395M 0.11% 189
2015
Q3
$9.03M Sell
159,934
-3,743,478
-96% -$211M ﹤0.01% 1198
2015
Q2
$231M Sell
3,903,412
-3,169,362
-45% -$187M 0.06% 295
2015
Q1
$441M Sell
7,072,774
-3,271,429
-32% -$204M 0.11% 184
2014
Q4
$595M Sell
10,344,203
-592,358
-5% -$34.1M 0.16% 136
2014
Q3
$588M Sell
10,936,561
-3,092,581
-22% -$166M 0.16% 137
2014
Q2
$735M Sell
14,029,142
-18,334,889
-57% -$961M 0.2% 111
2014
Q1
$1.71B Sell
32,364,031
-12,935,262
-29% -$683M 0.47% 47
2013
Q4
$1.82B Sell
45,299,293
-13,705,520
-23% -$549M 0.52% 39
2013
Q3
$2.23B Sell
59,004,813
-2,235,005
-4% -$84.4M 0.7% 24
2013
Q2
$2.4B Buy
+61,239,818
New +$2.4B 0.78% 20